Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://www.nature.com/articles/aps201293, but it redirected us to https://www.nature.com/articles/aps201293. The analysis below is for the second page.

Title[redir]:
Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition | Acta Pharmacologica Sinica
Description:
To investigate whether luteolin, a highly prevalent flavonoid, reverses the effects of epithelial-mesenchymal transition (EMT) in vitro and in vivo and to determine the mechanisms underlying this reversal. Murine malignant melanoma B16F10 cells were exposed to 1% O2 for 24 h. Cellular mobility and adhesion were assessed using Boyden chamber transwell assay and cell adhesion assay, respectively. EMT-related proteins, such as E-cadherin and N-cadherin, were examined using Western blotting. Female C57BL/6 mice (6 to 8 weeks old) were injected with B16F10 cells (1×106 cells in 0.2 mL per mouse) via the lateral tail vein. The mice were treated with luteolin (10 or 20 mg/kg, ip) daily for 23 d. On the 23rd day after tumor injection, the mice were sacrificed, and the lungs were collected, and metastatic foci in the lung surfaces were photographed. Tissue sections were analyzed with immunohistochemistry and HE staining. Hypoxia changed the morphology of B16F10 cells in vitro from the cobblestone-like to mesenchymal-like strips, which was accompanied by increased cellular adhesion and invasion. Luteolin (5−50 μmol/L) suppressed the hypoxia-induced changes in the cells in a dose-dependent manner. Hypoxia significantly decreased the expression of E-cadherin while increased the expression of N-cadherin in the cells (indicating the occurrence of EMT-like transformation), which was reversed by luteolin (5 μmol/L). In B16F10 cells, luteolin up-regulated E-cadherin at least partly via inhibiting the β3 integrin/FAK signal pathway. In experimental metastasis model mice, treatment with luteolin (10 or 20 mg/kg) reduced metastatic colonization in the lungs by 50%. Furthermore, the treatment increased the expression of E-cadherin while reduced the expression of vimentin and β3 integrin in the tumor tissues. Luteolin inhibits the hypoxia-induced EMT in malignant melanoma cells both in vitro and in vivo via the regulation of β3 integrin, suggesting that luteolin may be applied as a potential anticancer chemopreventative and chemotherapeutic agent.

Matching Content Categories {📚}

  • Science
  • Education
  • Telecommunications

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cells, luteolin, article, emt, cell, melanoma, google, scholar, cancer, cas, expression, ecadherin, tumor, metastasis, integrin, transition, nature, figure, hypoxia, μmoll, epithelialmesenchymal, mice, lung, analysis, malignant, adhesion, ncadherin, control, wang, hypoxiainduced, potential, liu, zhang, vitro, invasion, vimentin, inhibits, growth, medium, china, incubated, jiangsu, ruan, metastatic, results, model, treatment, human, content, data,

Topics {✒️}

nature portfolio nf-kappab/snail/rkip/pten circuit permissions reprints privacy policy nature pollution research advertising open project e-cadherin-regulating transcription factors culture media shao-ming wang specific pathogen-free conditions integrin/fak signal pathway epithelial-derived cancers21 jun-shan ruan tris-buffered saline-tween-20 social media hypoxia-induced cell adhesion epithelial-mesenchymal transition uvb-induced skin cancer full size image yu-ping liu wrote author correspondence shi-zhong zheng natural science foundation squamous-cell carcinoma potential anti-tumor capacity12 development permissions common human cancers yin lu designed mesenchymal cell state cutaneous malignant melanoma emt-related genes promoted cun-si shen performed acta pharmacol sin epithelial-mesenchymal transitions elicit anti-emt effects jiangsu key laboratory hypoxia-induced model original cobblestone hypoxia-induced switching inhibiting stat3 signaling targeting β3 integrin cell culture model article ruan cell growth factors anti-tumor activity privacy optimas image analyzer

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition
         description:To investigate whether luteolin, a highly prevalent flavonoid, reverses the effects of epithelial-mesenchymal transition (EMT) in vitro and in vivo and to determine the mechanisms underlying this reversal. Murine malignant melanoma B16F10 cells were exposed to 1% O2 for 24 h. Cellular mobility and adhesion were assessed using Boyden chamber transwell assay and cell adhesion assay, respectively. EMT-related proteins, such as E-cadherin and N-cadherin, were examined using Western blotting. Female C57BL/6 mice (6 to 8 weeks old) were injected with B16F10 cells (1×106 cells in 0.2 mL per mouse) via the lateral tail vein. The mice were treated with luteolin (10 or 20 mg/kg, ip) daily for 23 d. On the 23rd day after tumor injection, the mice were sacrificed, and the lungs were collected, and metastatic foci in the lung surfaces were photographed. Tissue sections were analyzed with immunohistochemistry and HE staining. Hypoxia changed the morphology of B16F10 cells in vitro from the cobblestone-like to mesenchymal-like strips, which was accompanied by increased cellular adhesion and invasion. Luteolin (5−50 μmol/L) suppressed the hypoxia-induced changes in the cells in a dose-dependent manner. Hypoxia significantly decreased the expression of E-cadherin while increased the expression of N-cadherin in the cells (indicating the occurrence of EMT-like transformation), which was reversed by luteolin (5 μmol/L). In B16F10 cells, luteolin up-regulated E-cadherin at least partly via inhibiting the β3 integrin/FAK signal pathway. In experimental metastasis model mice, treatment with luteolin (10 or 20 mg/kg) reduced metastatic colonization in the lungs by 50%. Furthermore, the treatment increased the expression of E-cadherin while reduced the expression of vimentin and β3 integrin in the tumor tissues. Luteolin inhibits the hypoxia-induced EMT in malignant melanoma cells both in vitro and in vivo via the regulation of β3 integrin, suggesting that luteolin may be applied as a potential anticancer chemopreventative and chemotherapeutic agent.
         datePublished:2012-09-17T00:00:00Z
         dateModified:2012-09-17T00:00:00Z
         pageStart:1325
         pageEnd:1331
         sameAs:https://doi.org/10.1038/aps.2012.93
         keywords:
            luteolin
            epithelial mesenchymal transition
            melanoma
            hypoxia
            E-cadherin
            N-cadherin
            Î²3 integrin FAK
            Biomedicine
            general
            Pharmacology/Toxicology
            Medical Microbiology
            Immunology
            Internal Medicine
            Vaccine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig4_HTML.jpg
         isPartOf:
            name:Acta Pharmacologica Sinica
            issn:
               1745-7254
               1671-4083
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jun-shan Ruan
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
                     address:
                        name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu-ping Liu
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lei Zhang
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ling-geng Yan
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fang-tian Fan
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cun-si Shen
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ai-yun Wang
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shi-zhong Zheng
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shao-ming Wang
               affiliation:
                     name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
                     address:
                        name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yin Lu
               affiliation:
                     name:College of Pharmacy, Nanjing University of Chinese Medicine
                     address:
                        name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
                     address:
                        name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition
      description:To investigate whether luteolin, a highly prevalent flavonoid, reverses the effects of epithelial-mesenchymal transition (EMT) in vitro and in vivo and to determine the mechanisms underlying this reversal. Murine malignant melanoma B16F10 cells were exposed to 1% O2 for 24 h. Cellular mobility and adhesion were assessed using Boyden chamber transwell assay and cell adhesion assay, respectively. EMT-related proteins, such as E-cadherin and N-cadherin, were examined using Western blotting. Female C57BL/6 mice (6 to 8 weeks old) were injected with B16F10 cells (1×106 cells in 0.2 mL per mouse) via the lateral tail vein. The mice were treated with luteolin (10 or 20 mg/kg, ip) daily for 23 d. On the 23rd day after tumor injection, the mice were sacrificed, and the lungs were collected, and metastatic foci in the lung surfaces were photographed. Tissue sections were analyzed with immunohistochemistry and HE staining. Hypoxia changed the morphology of B16F10 cells in vitro from the cobblestone-like to mesenchymal-like strips, which was accompanied by increased cellular adhesion and invasion. Luteolin (5−50 μmol/L) suppressed the hypoxia-induced changes in the cells in a dose-dependent manner. Hypoxia significantly decreased the expression of E-cadherin while increased the expression of N-cadherin in the cells (indicating the occurrence of EMT-like transformation), which was reversed by luteolin (5 μmol/L). In B16F10 cells, luteolin up-regulated E-cadherin at least partly via inhibiting the β3 integrin/FAK signal pathway. In experimental metastasis model mice, treatment with luteolin (10 or 20 mg/kg) reduced metastatic colonization in the lungs by 50%. Furthermore, the treatment increased the expression of E-cadherin while reduced the expression of vimentin and β3 integrin in the tumor tissues. Luteolin inhibits the hypoxia-induced EMT in malignant melanoma cells both in vitro and in vivo via the regulation of β3 integrin, suggesting that luteolin may be applied as a potential anticancer chemopreventative and chemotherapeutic agent.
      datePublished:2012-09-17T00:00:00Z
      dateModified:2012-09-17T00:00:00Z
      pageStart:1325
      pageEnd:1331
      sameAs:https://doi.org/10.1038/aps.2012.93
      keywords:
         luteolin
         epithelial mesenchymal transition
         melanoma
         hypoxia
         E-cadherin
         N-cadherin
         Î²3 integrin FAK
         Biomedicine
         general
         Pharmacology/Toxicology
         Medical Microbiology
         Immunology
         Internal Medicine
         Vaccine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig4_HTML.jpg
      isPartOf:
         name:Acta Pharmacologica Sinica
         issn:
            1745-7254
            1671-4083
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jun-shan Ruan
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
                  address:
                     name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu-ping Liu
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lei Zhang
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ling-geng Yan
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fang-tian Fan
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cun-si Shen
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ai-yun Wang
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shi-zhong Zheng
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shao-ming Wang
            affiliation:
                  name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
                  address:
                     name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yin Lu
            affiliation:
                  name:College of Pharmacy, Nanjing University of Chinese Medicine
                  address:
                     name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
                  address:
                     name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Acta Pharmacologica Sinica
      issn:
         1745-7254
         1671-4083
      volumeNumber:33
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
      address:
         name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
      address:
         name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
         type:PostalAddress
      name:College of Pharmacy, Nanjing University of Chinese Medicine
      address:
         name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
      name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
      address:
         name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jun-shan Ruan
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
            name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
            address:
               name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
               type:PostalAddress
            type:Organization
      name:Yu-ping Liu
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Lei Zhang
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Ling-geng Yan
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Fang-tian Fan
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Cun-si Shen
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Ai-yun Wang
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Shi-zhong Zheng
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Shao-ming Wang
      affiliation:
            name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
            address:
               name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
               type:PostalAddress
            type:Organization
      name:Yin Lu
      affiliation:
            name:College of Pharmacy, Nanjing University of Chinese Medicine
            address:
               name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
            name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
            address:
               name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
      name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
      name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China

External Links {🔗}(242)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.13s.